Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Sweet science: honey may help fight insulin resistance

NCT ID NCT05427799

Disease control Sponsor: University of Jordan Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether eating honey every day could help obese women with insulin resistance, a condition that can lead to diabetes. Twenty women took part, consuming honey or a sugar-based alternative for a set period. Researchers measured blood sugar, insulin, and other health markers to see if honey made a difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
honey
What this could lead to
If honey helps, it could offer a natural way to improve insulin sensitivity and reduce diabetes risk in obese women.
What could go wrong
This was a very small trial (20 women) with no phase, so results are preliminary. Honey is still sugar and may not benefit everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

20 people

The number who actually took part.

Started

Mar 2022

Finished

Nov 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female * 19-45 years * Obese (BMI \>= 30 kg/m\^2) * Premenopausal Exclusion Criteria: * Individual who use any drug or supplements known to affect lipid, glucose for at least the last three months. * Individual who previous insulin treatment * Smokers * Individual who have diabetes, kidney, liver, or hormonal diseases * Individual who have significant weight changes \> 5% during the past 6 months * Women who are postmenopausal

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Insulin resistance are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Insulin Resistance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Insulin resistance

Contacts and locations

Locations

  • Jordan University Hospital

    Amman, Amman, Jordan, 11942, Jordan

  • The University of Jordan

    Amman, Amman, Jordan, 11942, Jordan

More trials for these conditions

Other studies related to the condition(s) this trial covers.